Citigroup reiterated a neutral rating on Sanofi stock while Morgan Stanley boosted its holdings.
3 reports, 1 independent
Updated Sep 25
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reiterated a neutral rating on Sanofi stock while Morgan Stanley boosted its holdings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
French pharmaceutical company
-
Morgan Stanley
U.S. investment bank
Related events
- Citigroup restated a buy rating on SAP shares, and Morgan Stanley reiterated an overweight rating on the company.
- Morgan Stanley reaffirmed an underweight rating and Citigroup restated a sell rating on Handelsbanken, reported by MarketBeat.
- Citigroup upgraded Next plc to a buy rating, while Santander and Morgan Stanley also issued rating updates on the company.
- Citigroup and Morgan Stanley provided price target and rating updates for Altria on November 4, 2026.
- Sodexo received multiple rating updates from Citigroup, Morgan Stanley, and Royal Bank of Canada, according to MarketBeat.